Symptom guide

Hot flashes and night sweats

A wave of heat that comes from nowhere. Your face flushing. Waking up soaked at 3am. Hot flashes and night sweats are the most well-known symptoms of perimenopause — and also the most undertreated.

The Menopause Clinic7 minute readPatient education


Here's what's actually happening

Hot flashes happen because your brain's internal thermostat stops working properly. Under normal circumstances, your body has a comfortable temperature range it stays within — a zone where it doesn't feel the need to cool you down or warm you up. Estrogen helps maintain that zone. When estrogen declines, that zone narrows dramatically. Your body becomes hypersensitive to even tiny changes in your core temperature — and it responds by triggering a heat-release response: flushing, sweating, a sudden wave of heat, and then often a chill as your body overshoots.

The reason this happens involves a cluster of nerve cells in the brain that regulate both temperature and reproductive hormones. When estrogen is present, these cells stay relatively quiet. When estrogen drops, they become overactive and start firing when they shouldn't — sending a false alarm to your body's cooling system. Research into newer non-hormonal treatments has actually pinpointed exactly which receptors are involved, which is why those treatments work by blocking those specific signals.

Hot flashes are not just uncomfortable. They are physiologically significant events — each one involves a real change in your circulation, your heart rate, and your skin temperature. For women who have them frequently, the cumulative effect on sleep, mood, and daily functioning is substantial.

How common are they, and how long do they last?

Between 50% and 80% of women experience hot flashes during perimenopause and menopause. About 87% of those women have them every single day, and roughly a third have more than ten episodes a day. That is not a minor inconvenience — that is a condition that disrupts work, sleep, relationships, and quality of life around the clock.

One of the most important things to know is how long they last. The old assumption was a few years. The reality is much longer. Research now shows that vasomotor symptoms persist for a median of 7 to 10 years — and about one in three women continues to have moderate to severe symptoms for more than a decade. They typically peak in the late perimenopause period and the two years following the last period, but for many women they don't simply stop after that.

In perimenopause vs. menopause

In perimenopause, hot flashes often come and go with hormonal fluctuation. Some cycles are worse than others. Women may have stretches of relative relief followed by flares, which can make it hard to know what's a pattern and what's random. Night sweats during this stage are often the first sign, showing up as disrupted sleep before the daytime hot flashes become obvious.

After the final period, symptoms typically intensify before they begin to taper. For some women they fade within a few years. For others they persist well into their sixties. Black women statistically experience vasomotor symptoms for the longest duration — a median of 10 years — and this is an important consideration in treatment planning.

What this means for your care

Hormone therapy is the most effective treatment for hot flashes by a significant margin. It reduces frequency by about 75% and severity by about 87%. For comparison, non-hormonal medications like certain antidepressants reduce symptoms by 40 to 65%. Both oral and transdermal estrogen are effective. The mechanism is straightforward: estrogen widens the thermoregulatory zone back toward normal and quiets the overactive nerve signals that were triggering the false alarms.

Most women notice improvement within two weeks at standard doses. Some may take up to eight weeks. The goal is not perfection — some women find a dose that eliminates hot flashes entirely, while others find a level that makes them manageable. Either outcome is meaningful, especially given what unmanaged hot flashes do to sleep, mood, and cognitive function over time.

What hot flashes and night sweats tell us about your heart

This is the part most women are never told. Hot flashes and night sweats are not just uncomfortable — research shows they are a signal worth paying attention to for your long-term cardiovascular health.

Women with severe hot flashes have an 83% increased risk of cardiovascular disease compared to women without them. Severe night sweats are associated with a 59% increased risk. These associations hold even after accounting for other cardiovascular risk factors like cholesterol, blood pressure, and blood sugar. In other words, hot flashes and night sweats appear to be an independent signal — something the body is telling us about what's happening in the blood vessels.

The research also shows that persistence matters more than frequency. Women whose symptoms are severe and stick around over time have the highest cardiovascular risk — up to 77% higher than women without persistent symptoms. And early onset matters too: women who develop hot flashes early in the transition show measurable changes in the arteries, including thicker arterial walls, that are independent of other risk factors.

The mechanism appears to involve the blood vessels directly. Women with severe hot flashes show reduced blood vessel flexibility, greater arterial stiffness, and signs of early atherosclerosis — the buildup inside artery walls that precedes heart disease — compared to women without them. Hot flashes may not cause this damage directly, but they appear to reflect and amplify the same underlying vascular vulnerability.

This does not mean every woman with hot flashes will develop heart disease. But it does mean that severe, persistent hot flashes and night sweats deserve to be taken seriously as a cardiovascular signal — not dismissed as a nuisance to wait out.

Hot flashes and night sweats are not just a nuisance. They are a signal that your body's regulatory systems are working without the hormonal support they've always relied on — and research now tells us that signal has real implications for your long-term health. Treating them matters.
Research

The sources behind this page

  • Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405-420.
  • Hickey M, LaCroix AZ, Doust J, et al. An Empowerment Model for Managing Menopause. Lancet. 2024.
  • Pinkerton JV. Hormone Therapy for Postmenopausal Women. N Engl J Med. 2020.
  • Pinkerton JV, Simon JA, Joffe H, et al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2. JAMA. 2024.
  • Lederman S, Ottery FD, Cano A, et al. Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms (SKYLIGHT 1). Lancet. 2023.
  • Nelson HD. Menopause. Lancet. 2008;371(9614):760-770.
  • Rossouw JE, Aragaki AK, Manson JE, et al. Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms. JAMA Intern Med. 2025.
  • Mosconi L, Berti V, Dyke J, et al. Menopause Impacts Human Brain Structure, Connectivity, Energy Metabolism, and Amyloid-Beta Deposition. Scientific Reports. 2021.
  • Zhu D, Chung HF, Dobson AJ, et al. Vasomotor Menopausal Symptoms and Risk of Cardiovascular Disease: A Pooled Analysis. Am J Obstet Gynecol. 2020.
  • Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. J Am Heart Assoc. 2021.
  • El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause Transition and Cardiovascular Disease Risk. Circulation. 2020.
  • Dastmalchi LN, Gulati M, Thurston RC, et al. Improving Cardiovascular Clinical Competencies for the Menopausal Transition. JACC Advances. 2025.